Simultaneous blockade of costimulatory signals CD28-CD80 and CD40-CD154 combined with monoclonal antibody against CD25 induced a stable chimerism and tolerance without Graft-versus-Host disease in rat

European Surgical Research

Volumn 46, Issue 3, 2011, Pages 109-117

  Zhu, Z X ^a   Fan, L Y ^b   Wang, Q ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

Apoptosis; Chimerism; Costimulatory signals; Graft versus host disease; Tolerance

Indexed keywords

ABATACEPT; CD40 LIGAND MONOCLONAL ANTIBODY; INTERLEUKIN 2 RECEPTOR ANTIBODY; M 90; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BONE MARROW TRANSPLANTATION; CHIMERA; CONTROLLED STUDY; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SKIN GRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; ANTIGENS, CD40; ANTIGENS, CD80; APOPTOSIS; BONE MARROW TRANSPLANTATION; CD40 LIGAND; GRAFT VS HOST DISEASE; IMMUNOCONJUGATES; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; RATS; RATS, INBRED BN; RATS, INBRED LEW; SKIN TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION TOLERANCE;

EID: 78651380632     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000323011     Document Type: Article

References (45)

1. Muramatsu K, Kuriyama R, You-Xin S, Hashimoto T, Matsunaga T, Taguchi T: Chimerism studies as an approach for the induction of tolerance to extremity allografts. J Plast Reconstr Aesthet Surg 2008; 61: 1009-1015.
2. Owen RD: Immunogenetic consequences of vascular anastomoses between bovine twins. Science 1945; 102: 400-401.
3. Li S, Salgar SK, Kurimoto Y, Yousem S, Pham SM: Mixed chimerism achieved by a nonlethal conditioning regimen induces donorspecific tolerance to lung allografts. J Surg Res 2008; 146: 289-297.
4. Sykes M, Szot GL, Swenson KA, Pearson DA: Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning. Nat Med 1997; 3: 783-787. (Pubitemid 27298725)
5. Wang GM, Ma JB, Jin YZ, Feng YG, Hao J, Gao X, Xie SS: Long-term survival of cardiac allografts induced by cyclophosphamide combined with CTLA4Ig-gene transfer mediated by adenoviral vector. Transplant Proc 2006; 38: 3043-3045. (Pubitemid 44737974)
6. Thiel MA, Steiger JU, O'Connell PJ, Lehnert AM, Coster DJ, Williams KA: Local or shortterm systemic costimulatory molecule blockade prolongs rat corneal allograft survival. Clin Experiment Ophthalmol 2005; 33: 176-180. (Pubitemid 40662783)
7. Watanabe T, Miyatake T, Kumamoto H, Mafune N, Kubota S, Okamoto H, Murashita T, Uede T, Yasuda K: Adenovirus-mediated CTLA4 immunoglobulin G gene therapy in cardiac xenotransplantation. Transplant Proc 2004; 36: 2478-2479. (Pubitemid 39550882)
8. Yuan X, Dong VM, Coito AJ, Waaga AM, Salama AD, Benjamin CD, Sayegh MH, Chandraker A: A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection. Transplantation 2002; 73: 1736-1742. (Pubitemid 34655248)
9. Im SH, Barchan D, Maiti PK, Fuchs S, Souroujon MC: Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4. J Immunol 2001; 166: 6893-6898. (Pubitemid 32467236)
10. di Filippo S: Anti-IL-2 receptor antibody vs polyclonal anti-lymphocyte antibody as induction therapy in pediatric transplantation. Pediatr Transplant 2005; 9: 373-380. (Pubitemid 40780371)
11. Kaplan B, West P, Neeley H, Martellotto J, Iqbal R, Gangemi A, Hatipoglu B, Benedetti E, Oberholzer J: Use of low-dose tacrolimus, mycophenolate mofetil and maintenance IL-2 receptor blockade in an islet transplant recipient. Clin Transplant 2008; 22: 250-253. (Pubitemid 351420022)
12. Pinana JL, Valcarcel D, Martino R, Moreno ME, Sureda A, Briones J, Brunet S, Sierra J: Encouraging results with inolimomab (anti- IL-2 receptor) as treatment for refractory acute graft-versus-host disease. Biol Blood Marrow Transplant 2006; 12: 1135-1141. (Pubitemid 44660853)
13. Vallera DA, Blazar BR: T cell depletion for graft-versus-host-disease prophylaxis: a perspective on engraftment in mice and humans. Transplantation 1989; 47: 751-760. (Pubitemid 19139107)
14. Abou el-Ezz AY, Boggs SS, Johnson PC, Li H, Patrene KD, Itskowitz MS, Kaufman CL, Ildstad ST: A minimal conditioning approach to achieve stable multilineage mouse plus rat chimerism. Transpl Immunol 1995; 3: 98-106.
15. Taylor PA, Lees CJ, Waldmann H, Noelle RJ, Blazar BR: Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions. Blood 2001; 98: 467-474.
16. Colson YL, Zadach K, Nalesnik M, Ildstad ST: Mixed allogeneic chimerism in the rat: donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts. Transplantation 1995; 60: 971-980.
17. Engh E, Strøm-Gundersen I, Benestad HB, Rolstad B: Long-term donor chimerism after MHC (RT1) mismatched bone marrow transplantation in the rat: the role of host alloreactive NK cells. Scand J Immunol 2001; 54: 198-203. (Pubitemid 32592346)
18. Okayama J, Ko S, Kanehiro H, Kanokogi H, Hisanaga M, Ohashi K, Sho M, Nagao M, Ikeda N, Kanamura T, Akashi S, Nakajima Y: Bone marrow chimerism and tolerance induced by single-dose cyclophosphamide. J Surg Res 2004; 120: 102-110. (Pubitemid 38686536)
19. Poynton CH: T cell depletion in bone marrow transplantation. Bone Marrow Transplant 1988; 3: 265-279.
20. Hows JM, Chapple M, Marsh JC, Durrant S, Yin JL, Swirsky D, Gordon-Smith EC: Bone marrow transplantation for Fanconi's anaemia: the Hammersmith experience 1977-89. Bone Marrow Transplant 1989; 4: 629-634. (Pubitemid 20020746)
21. Jankowski RA, Ildstad ST: Chimerism and tolerance: from freemartin cattle and neonatal mice to humans. Hum Immunol 1997; 52: 155-161. (Pubitemid 27147139)
22. Liang Y, Huang T, Zhang C, Todorov I, Atkinson M, Kandeel F, Forman S, Zeng D: Donor CD8+ T cells facilitate induction of chimerism and tolerance without GVHD in autoimmune NOD mice conditioned with anti-CD3 mAb. Blood 2005; 105: 2180-2188. (Pubitemid 40731811)
23. Foster RD, Pham S, Li S, Aitouche A: Longterm acceptance of composite tissue allografts through mixed chimerism and CD28 blockade. Transplantation 2003; 76: 988-994. (Pubitemid 37186033)
24. Blaha P, Bigenzahn S, Koporc Z, Sykes M, Muehlbacher F, Wekerle T: Short-term immunosuppression facilitates induction of mixed chimerism and tolerance after bone marrow transplantation without cytoreductive conditioning. Transplantation 2005; 80: 237-243. (Pubitemid 41061681)
25. Guo L, Fujino M, Kimura H, Funeshima N, Kitazawa Y, Harihara Y, Tezuka K, Makuuchi M, Suzuki S, Li XK: AdCTLA-4Ig combined with donor splenocytes, bone marrow cells and anti-ICOS antibody treatment induce tolerance in a rat heart transplantation model. Transpl Int 2004; 17: 15-21. (Pubitemid 38197022)
26. Blaha P, Bigenzahn S, Koporc Z, Schmid M, Langer F, Selzer E, Bergmeister H, Wrba F, Kurtz J, Kiss C, Roth E, Muehlbacher F, Sykes M, Wekerle T: The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade. Blood 2003; 101: 2886-2893. (Pubitemid 36857658)
27. Malek TR, Yu A, Vincek V, Scibelli P, Kong L: CD4 regulatory T cells prevent lethal autoimmunity in IL-2R-deficient mice: implications for the nonredundant function of IL-2. Immunity 2002; 17: 167-178.
28. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I: Ulcerative colitis-like disease in mice with a disrupted interleukin- 2 gene. Cell 1993; 75: 253-261. (Pubitemid 23320289)
29. Patlolla V, Zhong X, Reed GW, Mandelbrot DA: Efficacy of anti-IL-2 receptor antibodies compared to no induction and to antilymphocyte antibodies in renal transplantation. Am J Transplant 2007; 7: 1832-1841. (Pubitemid 46905449)
30. Villegas EN, Lieberman LA, Mason N, Blass SL, Zediak VP, Peach R, Horan T, Yoshinaga S, Hunter CA: A role for inducible costimulator protein in the CD28-independent mechanism of resistance to Toxoplasma gondii. J Immunol 2002; 169: 937-943. (Pubitemid 34753451)
31. Shiraishi T, Yasunami Y, Takehara M, Uede T, Kawahara K, Shirakusa T: Prevention of acute lung allograft rejection in rat by CTLA4Ig. Am J Transplant 2002; 2: 223-228. (Pubitemid 36330239)
32. Nabeyama K, Yasunami Y, Toyofuku A, Nakano M, Satoh M, Matsuoka N, Ono J, Kamada M, Uede T, Todo S, Ikeda S: Beneficial effects of costimulatory blockade with antiinducible costimulator antibody in conjunction with CTLA4Ig on prevention of islet xenograft rejection from rat to mouse. Transplantation 2004; 78: 1590-1596. (Pubitemid 39648430)
33. Cheung ST, Tsui TY, Wang WL, Yang ZF, Wong SY, Ip YC, Luk J, Fan ST: Liver as an ideal target for gene therapy: expression of CTLA4Ig by retroviral gene transfer. J Gastroenterol Hepatol 2002; 17: 1008-1014.
34. Pan XC, Guo L, Deng YB, Naruse K, Kimura H, Sugawara Y, Makuuchi M: Further study of anti-ICOS immunotherapy for rat cardiac allograft rejection. Surg Today 2008; 38: 815-825.
35. Pan H, Lu HM, Hu WM, Tian BL, Liu XB, Zhang ZD, Mai G: Anti-CD25 mAb, anti-IL2 mAb, and IL2 block tolerance induction through anti-CD154 mAb and rapamycin in xenogeneic islet transplantation. Transplant Proc 2007; 39: 3452-3454. (Pubitemid 350251481)
36. Camirand G, Rousseau J, Ducharme ME, Rothstein DM, Tremblay JP: Novel Duchenne muscular dystrophy treatment through myoblast transplantation tolerance with anti-CD45RB, anti-CD154 and mixed chimerism. Am J Transplant 2004; 4: 1255-1265. (Pubitemid 39013571)
37. Kanaya K, Tsuchida Y, Inobe M, Murakami M, Hirose T, Kon S, Kawaguchi S, Wada T, Yamashita T, Ishii S, Uede T: Combined gene therapy with adenovirus vectors containing CTLA4Ig and CD40Ig prolongs survival of composite tissue allografts in rat model. Transplantation 2003; 75: 275-281. (Pubitemid 36222949)
38. Wekerle T, Sayegh MH, Hill J, Zhao Y, Chandraker A, Swenson KG, Zhao G, Sykes M: Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J Exp Med 1998; 187: 2037-2044. (Pubitemid 28285573)
39. Lu L, Li W, Zhong C, Qian S, Fung JJ, Thomson AW, Starzl TE: Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb. Transplantation 1999; 68: 747-757. (Pubitemid 29468192)
40. Honey K, Bemelman F, Cobbold SP, Waldmann H: High dose bone marrow transplantation induces deletion of antigen-specific T cells in a Fas-independent manner. Transplantation 2000; 69: 1676-1682.
41. Li JM, Gorechlad J, Larsen CP, Waller EK: Apoptotic donor leukocytes limit mixedchimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation. Biol Blood Marrow Transplant 2006; 12: 1239-1249. (Pubitemid 44858269)
42. Hoerbelt R, Johnston DR, Shoji T, Houser SL, Hasse RS, Ledgerwood LG, Iribarne A, Allan JS, Sayegh MH, Sachs DH, Madsen JC: Combination treatment with donor-specific transfusions and cyclosporine a induces long-term survival of cardiac allografts in miniature swine. Transplantation 2005; 80: 1275-1282. (Pubitemid 41746806)
43. Yang L, du Temple B, Khan Q, Zhang L: Mechanisms of long-term donor-specific allograft survival induced by pretransplant infusion of lymphocytes. Blood 1998; 91: 324-330. (Pubitemid 28018761)
44. Wells AD, Li XC, Li Y, Walsh MC, Zheng XX, Wu Z, Nuñez G, Tang A, Sayegh M, Hancock WW, Strom TB, Turka LA: Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med 1999; 5: 1303-1307. (Pubitemid 29535609)
45. van Parijs L, Abbas AK: Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 1998; 280: 243-248. (Pubitemid 28178061)